Stay updated on Chemoradiotherapy +/- Pembrolizumab in Cervical Cancer Clinical Trial
Sign up to get notified when there's something new on the Chemoradiotherapy +/- Pembrolizumab in Cervical Cancer Clinical Trial page.

Latest updates to the Chemoradiotherapy +/- Pembrolizumab in Cervical Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check18 days agoChange Detected- Results Submitted and Revision: v3.3.2 updates appear on the page, replacing 'No Results Posted' and Revision: v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check25 days agoChange DetectedAdded a clarifying note in Publications indicating that these entries are provided voluntarily by the person entering information about the study and pertain to the results, and recorded a new revision tag v3.3.1. The wording about publications relating to the study results was removed and the old revision v3.2.0 was deleted.SummaryDifference0.4%

- Check32 days agoChange DetectedThe government funding notice banner at the top of the page has been removed; no study details, locations, or eligibility information were changed.SummaryDifference0.1%

- Check46 days agoChange DetectedAdded two study locations in Cali, Valle del Cauca, Colombia (codes 760032 and 760042) and removed two locations listed as Santiago de Cali (760032 and 760042).SummaryDifference0.2%

- Check75 days agoChange DetectedMajor update to the page content includes a government-operating-status notice and a new version tag (v3.2.0), replacing the old version tag (v3.0.2).SummaryDifference1%

- Check76 days agoChange DetectedVersion bumped from v3.0.2 to v3.1.0; no other substantive content changes detected.SummaryDifference0.0%

Stay in the know with updates to Chemoradiotherapy +/- Pembrolizumab in Cervical Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Chemoradiotherapy +/- Pembrolizumab in Cervical Cancer Clinical Trial page.